Royal Bank Of Canada Blueprint Medicines Corp Transaction History

Royal Bank Of Canada

  • $528 Billion
  • Q2 2025

A detailed history of Royal Bank Of Canada transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 6,712 shares of BPMC stock, worth $868,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,712
Previous 26,814 74.97%
Holding current value
$868,935
Previous $2.37 Million 63.76%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$79.22 - $128.4 $1.59 Million - $2.58 Million
-20,102 Reduced 74.97%
6,712 $860,000
Q1 2025

May 15, 2025
BUY
$86.69 - $115.63 $1.55 Million - $2.07 Million
17,882 Added 200.2%
26,814 $2.37 Million
Q4 2024

Feb 14, 2025
SELL
$82.48 - $101.39 $665,778 - $818,420
-8,072 Reduced 47.47%
8,932 $779,000
Q3 2024

Nov 14, 2024
BUY
$84.1 - $120.5 $682,976 - $978,580
8,121 Added 91.42%
17,004 $1.57 Million
Q2 2024

Aug 14, 2024
BUY
$85.18 - $108.78 $374,451 - $478,196
4,396 Added 97.97%
8,883 $957,000
Q1 2024

Nov 05, 2024
SELL
$73.17 - $99.79 $321,655 - $438,676
-4,396 Reduced 49.49%
4,487 $425,000
Q1 2024

May 15, 2024
SELL
$73.17 - $99.79 $1.25 Million - $1.7 Million
-17,042 Reduced 79.16%
4,487 $425,000
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $459,645 - $970,735
10,456 Added 94.43%
21,529 $1.99 Million
Q3 2023

Nov 14, 2023
BUY
$46.9 - $66.0 $195,760 - $275,484
4,174 Added 60.5%
11,073 $556,000
Q2 2023

Aug 14, 2023
BUY
$42.2 - $66.37 $18,610 - $29,269
441 Added 6.83%
6,899 $436,000
Q1 2023

May 15, 2023
SELL
$37.97 - $50.0 $219,580 - $289,150
-5,783 Reduced 47.24%
6,458 $290,000
Q4 2022

Feb 14, 2023
BUY
$41.06 - $66.48 $348,968 - $565,013
8,499 Added 227.12%
12,241 $536,000
Q3 2022

Nov 14, 2022
SELL
$49.93 - $77.7 $49,430 - $76,923
-990 Reduced 20.92%
3,742 $246,000
Q2 2022

Aug 15, 2022
SELL
$45.23 - $70.15 $128,769 - $199,717
-2,847 Reduced 37.56%
4,732 $239,000
Q1 2022

May 16, 2022
SELL
$54.1 - $110.08 $556,851 - $1.13 Million
-10,293 Reduced 57.59%
7,579 $484,000
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $828,646 - $1.02 Million
8,792 Added 96.83%
17,872 $1.91 Million
Q3 2021

Nov 15, 2021
SELL
$80.98 - $109.47 $1.38 Million - $1.86 Million
-17,031 Reduced 65.23%
9,080 $934,000
Q2 2021

Aug 16, 2021
BUY
$82.78 - $101.0 $2.16 Million - $2.64 Million
26,111 New
26,111 $2.3 Million

Others Institutions Holding BPMC

# of Institutions
390
Shares Held
66.9M
Call Options Held
973K
Put Options Held
1.54M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.73B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email